NPY and post-traumatic stress disorder: In yohimbine, which is a noradrenergic α2-antagonist study, PTSD patients displayed reduced NPY concentrations in the plasma and blunted NPY responses as compared with controls suggesting that the lack of NPY can contribute to noradrenergic hyperactivity in PTSD [92].